1. Ahsan MJ, Sharma J, Singh M, Jadav SS, Yasmin S (2014) Synthesis and anticancer activity of N-Aryl-5-substituted-1,3,4-oxadiazol-2-amine analogues. Biomed Res Int 1:9–13
2. Boström J, Hogner A, Llinas A, Wellner E, Plowright AT (2012) Oxadiazoles in medicinal chemistry. J Med Chem 55:1817–1830
3. Bukely NJ, Bonner TI, Buckley CM, Brann MR (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35:469–476
4. Mills SD, Eakin AE, Buurman ET, Newman JV, Gao N, Huynh H, Johnson KD, Lahiri S, Shapiro AB (2011) Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo. Antimicrob Agents Chemother 55:1088–1096. other authors
5. Dorje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MRJ (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. Pharmacol Exp Ther 256:727–723